STUDIES ON THE SITE OF ACTION OF A CIRCULATING  ANTICOAGULANT IN DISSEMINATED LUPUS ERYTHEMATOSUS. EVIDENCE THAT THIS ANTICOAGULANT INHIBITS THE REACTION BETWEEN ACTIVATED STUART FACTOR (FACTOR X) AND PROACCELERIN (FACTOR V).
D000925:Anticoagulants; D001780:Blood Coagulation Tests; D004791:Enzyme Inhibitors; D005165:Factor V; D005170:Factor X; D006323:Heart Arrest; D007136:Immunoglobulins; D008180:Lupus Erythematosus, Systemic; D011516:Prothrombin
D000925:Anticoagulants; D004791:Enzyme Inhibitors; D007136:Immunoglobulins; C019158:circulating anticoagulants; D005165:Factor V; D011516:Prothrombin; D005170:Factor X
ANTICOAGULANTS; BLOOD COAGULATION TESTS; ENZYME INHIBITORS; FACTOR V; FACTOR X; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROTHROMBIN